Have a personal or library account? Click to login
Pharmacogenomic markers of glucocorticoid response in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia Cover

Pharmacogenomic markers of glucocorticoid response in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia

Radiology and Oncology
Volume 52 (2018): Issue 3 (September 2018)
By: Vladimir Gasic,  Branka Zukic,  Biljana Stankovic,  Dragana Janic,  Lidija Dokmanovic,  Jelena Lazic,  Nada Krstovski,  Vita Dolzan,  Janez Jazbec,  Sonja Pavlovic and  Nikola Kotur  
Open Access
|Sep 2018
DOI: https://doi.org/10.2478/raon-2018-0034 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 296 - 306
Submitted on: Feb 19, 2018
|
Accepted on: Apr 24, 2018
|
Published on: Sep 11, 2018
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
pharmacogenomics,
childhood ALL,
glucocorticoids,
glucocorticoid receptor gene,
glutathione S-transferase genes,
multidrug resistance 1 gene
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2018 Vladimir Gasic, Branka Zukic, Biljana Stankovic, Dragana Janic, Lidija Dokmanovic, Jelena Lazic, Nada Krstovski, Vita Dolzan, Janez Jazbec, Sonja Pavlovic, Nikola Kotur, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 52 (2018): Issue 3 (September 2018)Next article